BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2008
View Archived Issues
Alimera initiates enrollment in clinical trial of Medidur FA in conjunction with Lucentis
Read More
Rabeximod active in models of autoimmune diseases
Read More
Phase I study of Nexagon for healing after laser eye surgery recruiting patients
Read More
CY-503 evaluated in phase II stage IV malignant melanoma trial
Read More
DMXB-Anabaseine improves negative symptoms in phase II schizophrenia trial
Read More
Mechanisms behind anti-atherosclerotic effects of EP-80317 studied in ApoE-/- mice
Read More
Cholesterol lowering with AVE-5530 described in animals
Read More
Pipex receives FDA orphan drug designation for oral tetrathiomolybdate for IPF
Read More
FDA approves Taclonex Scalp for psoriasis of the scalp
Read More
Piramal Life Sciences initiates phase I trials with P-1736 for type 2 diabetes
Read More
Oncolytics initiates enrollment in REO 012 clinical trial of Reolysin and cyclophosphamide
Read More
Virostatics initiates dosing in phase IIa trial of VS-411 in HIV
Read More
NovaBay reports results from phase I trial of NVC-422 in prevention of CAUTI
Read More
Takeda and Affymax report results from three phase II trials of Hematide
Read More
New agents for infectious diseases described in recent CSIR and GSK patents
Read More
FDA grants marketing approval to Novalar's dental anesthetic reversal agent OraVerse
Read More
New therapeutic options for cancer reported in recent patents
Read More
Crucell initiates phase II clinical study in the Philippines of rabies monoclonal antibody
Read More
Ambrilia presents positive final phase III results for Octreotide C2L
Read More
ChemoCentryx commences clinical trial for CCX-354
Read More
Novel sEH inhibitor shows benefit in mouse model of obesity
Read More
FDA approves Seroquel for maintenance treatment in bipolar disorder
Read More
FDA grants orphan drug designation for SB-1518 in myeloproliferative disorders
Read More
Pharmasset doses two additional cohorts in R-7128 chronic hepatitis C trial
Read More
Intercell to acquire Iomai to expand late-stage product pipeline
Read More